FindTrial
Sign In

Prognostic Model Development to Predict Outcome in Neonatal Sepsis Patient

Development and Validation of Multivariate Prognostic Model based on Risk Factors and Inflammatory Markers to Predict Outcome in Neonatal Sepsis Patients - SSPONSP

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/01/016920
Enrollment
337
Registered
2019-01-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P36- Bacterial sepsis of newborn

Interventions

None listed

Sponsors

Manipal College of Pharmaceutical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Neonates with age less than or equal to 30 days of life with sepsis in hospital and cases with sepsis referred within 30 days of life will be included Neonates having culture sterile sepsis within or less than 30 days of life Neonatal sepsis patient diagnosed within or equal to 30 days of life with well defined outcome such as recovered/improved or expired

Exclusion criteria

Exclusion criteria: Neonatal sepsis patient with viral or fungal infection Patient having renal failure, congenital heart disease Neonatal sepsis patient discharge against medical advice

Design outcomes

Primary

MeasureTime frame
MortalityTimepoint: 30 days of life—

Secondary

MeasureTime frame
MortalityTimepoint: 30 days of life—

Countries

India

Contacts

Public ContactDr Krishnananda Prabhu

Manipal College of Pharmaceutical Sciences

vijayanarayana.k@manipal.edu91-9448255124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026